TITLE

Five pronged strategy

AUTHOR(S)
Desai, Suresh Thakur
PUB. DATE
December 1997
SOURCE
Chemical Business;Dec97, Vol. 11 Issue 5, p23
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the five-pronged strategy for bulk actives by Hyderabad, India-based Dr. Reddy's Laboratories to sustain its profitability.
ACCESSION #
601230

 

Related Articles

  • Dr Reddy's Laboratories--good show.  // Chemical Business;Jul98, Vol. 12 Issue 7, p116 

    Reports on the financial performance of the Dr. Reddy's Laboratories company in fiscal year 1997-98. Turnover growth of the formulations business; Formulations sales in India; Sales of the bulk drugs business.

  • Dr Reddy's to expand bulk drug activities.  // Chemical Business;Aug95, Vol. 9 Issue 1, p30 

    Reports that Indian company Dr. Reddy's Lab is contemplating expanding its activities in the fields of bulk drugs as also formulations. Set up of unit by company; Costs; Other expansion by company.

  • Dr. Reddy's seeks global patents for 4 products.  // Chemical Business;Jun95, Vol. 8 Issue 11, p64 

    Reports on Dr. Reddy's Laboratories' efforts to obtain world-wide patents for four of its products. Search for joint venture partners in Russia and China; Increased demand for cheap generic substitutes in the United States.

  • Dr. Reddy's Laboratories Inc.  // Pharmaceutical Technology;Dec2010 Supplement, p92 

    The article presents the corporate profile of Dr. Reddy's Laboratories Inc., located in Bridgewater, New Jersey, where it was established in 1984 and has 14,000 active employees.

  • Dr Reddy's launches Sildenafil tablets.  // BioSpectrum;Dec2012, Vol. 10 Issue 12, p14 

    The article reports that Sildenafil tablets, a bioequivalent generic version of REVATIO (Sildenafil) tablets, has been launched by Dr. Reddy's Laboratories.

  • DRL donates Rs 2 crs to Hudhud cyclone relief fund.  // Express Pharma;03/16/2014, p2 

    The article reports on the donation of Dr. Reddy's Laboratories Ltd. of about Rs two crores to Hudhud cyclone relief fund in a bid to help restore the lives of the people affected by the cyclone in Visakhapatnam.

  • DRL launches esomeprazole magnesium delayed-release capsules.  // Express Pharma;9/28/2015, p1 

    The article reports on the launch of esomeprazole magnesium delayed-relese capsules by Dr. Reddy's Laboratories Ltd. (DRL) in the U.S. market on September 25, 2015.

  • Dr Reddy's lotion for vitiligo.  // BioSpectrum;Jul2014, Vol. 12 Issue 7, p14 

    The article reports on the launch of a Melgain lotion by pharmaceutical giant Dr. Reddy's Laboratories Ltd. in-licensed with city-based Issar Pharmaceuticals for the domestic market.

  • Dr. Reddy's Laboratories submits press release.  // Ace Analyser: Company News;6/14/2019, pN.PAG 

    The article informs that Dr. Reddy's Laboratories has announced entering into a definitive agreement to sell its neurology branded products to Upsher-Smith Laboratories LLC.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics